HighMark Wealth Management LLC Acquires 1,380 Shares of CVS Health Corporation $CVS

HighMark Wealth Management LLC lifted its stake in shares of CVS Health Corporation (NYSE:CVS) by 266.9% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 1,897 shares of the pharmacy operator’s stock after acquiring an additional 1,380 shares during the period. HighMark Wealth Management LLC’s holdings in CVS Health were worth $131,000 at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of the stock. Bell Investment Advisors Inc raised its holdings in shares of CVS Health by 119.8% during the first quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock valued at $31,000 after purchasing an additional 248 shares during the period. Roxbury Financial LLC boosted its holdings in CVS Health by 78.3% in the second quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock worth $32,000 after acquiring an additional 202 shares in the last quarter. ORG Partners LLC grew its stake in CVS Health by 418.9% in the second quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock valued at $32,000 after acquiring an additional 377 shares during the period. Saudi Central Bank bought a new stake in shares of CVS Health during the first quarter valued at approximately $34,000. Finally, Livelsberger Financial Advisory acquired a new position in shares of CVS Health during the second quarter worth approximately $35,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other CVS Health news, Director Anne A. Finucane sold 7,500 shares of the business’s stock in a transaction dated Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total value of $532,650.00. Following the transaction, the director directly owned 22,156 shares in the company, valued at $1,573,519.12. The trade was a 25.29% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.22% of the stock is currently owned by insiders.

CVS Health Stock Performance

Shares of CVS opened at $77.48 on Friday. The stock has a 50 day moving average of $70.37 and a 200 day moving average of $67.27. The company has a market capitalization of $98.27 billion, a price-to-earnings ratio of 21.64, a PEG ratio of 0.85 and a beta of 0.60. CVS Health Corporation has a 12 month low of $43.56 and a 12 month high of $77.76. The company has a current ratio of 0.80, a quick ratio of 0.62 and a debt-to-equity ratio of 0.74.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.46 by $0.35. CVS Health had a return on equity of 10.51% and a net margin of 1.17%.The firm had revenue of $98.92 billion during the quarter, compared to the consensus estimate of $94.87 billion. During the same quarter in the prior year, the company earned $1.83 EPS. The business’s revenue for the quarter was up 8.4% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, sell-side analysts forecast that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 3rd. Investors of record on Thursday, October 23rd will be issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 3.4%. The ex-dividend date is Thursday, October 23rd. CVS Health’s dividend payout ratio (DPR) is 74.30%.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on CVS shares. Morgan Stanley lifted their price objective on shares of CVS Health from $80.00 to $82.00 and gave the company an “overweight” rating in a report on Friday, August 1st. Barclays lifted their price target on CVS Health from $80.00 to $87.00 and gave the company an “overweight” rating in a research note on Thursday, September 4th. Wolfe Research increased their price objective on CVS Health from $80.00 to $85.00 and gave the stock an “outperform” rating in a research note on Monday, September 22nd. Baird R W raised CVS Health from a “hold” rating to a “strong-buy” rating in a research report on Thursday, August 14th. Finally, Cowen reissued a “buy” rating on shares of CVS Health in a research report on Monday, August 4th. Two research analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $78.25.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.